We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
In diesem 30-minütigen Webinar erläutern Fachleute von OCT Clinical das Genehmigungsverfahren für klinische Studien, einschließlich der Genehmigung von der Ethikkommission. Die Referenten werden auch die Anforderungen an Import- und Exportlizenzen sowie an die Pharmakovigilanz erörtern und Tipps zur Beschleunigung des Genehmigungsverfahrens geben.
Redner: Natalja Eliseewa, Senior Manager für regulatorische Angelegenheiten, OCT Clinical
Anna Janaewa, Leiterin der Entwicklungsabteilung, OCT Clinical
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
